Daily non-political popular news in brief.

Schizophrenia Plus and Minus: Cognitive course nudges patients into workforce

03-10-2007 · Science News Online

Antipsychotic drugs exert disappointingly modest effects on the quality of life of people with schizophrenia, although a new cognitive-training program shows promise as a way to get these psychiatric patients into the workforce.

Keywords: schizophrenia, plus, minus, cognitive, course, nudges, patients, workforce, plu, minu, nudge, patient

« Previous | Next »

Similar news on "Schizophrenia Plus and Minus: Cognitive course nudges patients into workforce":

Scientists identify 2 distinct Parkinson's networks
07-09-2007 · EurekAlert!
Parkinson's that causes tremors, rigidity and slowed movements also targets another brain network that regulates cognitive thought and the ability to carry out everyday tasks. David Eidelberg, MD, head of the Center for Neurosciences at the Feinstein Institute for Medical Research, and his colleagues measured and quantified this network of brain regions during a five-year study of newly diagnosed Parkinson's patients who agreed to be followed several times over the course of the study.
Similar news · Read more »
24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus
11-02-2007 · EurekAlert!
A group at Hiroshima University Hospital performed a matched historical controlled study on whether a 24-week course of interferon-alpha therapy, after curative treatment for primary hepatocellular carcinoma associated with hepatitis C virus, could influence tumor recurrence, patient survival, and liver function. Patients with sustained virological responses had reduced recurrence, prolonged survival and a preserved liver function. The group also determined that viral eradication was the most important factor in such patients.
Similar news · Read more »
Rheumatoid arthritis sends many into early retirement
02-04-2008 · EurekAlert!
A joint study on "The Burden of Rheumatoid Arthritis and Patient Access to Treatments" by authors from the Stockholm School of Economics, the University of Lund and the Medical University of Vienna has shown that the highest cost in rheumatoid arthritis results from patients having to leave the workforce early due to the disease. The study has just been published online in a supplement to Springer's The European Journal of Health Economics.
Similar news · Read more »
TB test offers patients quicker and easier diagnosis
06-01-2007 · EurekAlert!
A new test for diagnosing TB offers a quick and simple alternative to existing three-day methods, according to research published today in the journal Clinical Infectious Diseases. The study shows that the test, which involves taking three sputum samples from a patient over the course of one day, is just as effective as other more invasive and complicated testing methods, which take three days.
Similar news · Read more »
Study shows cognitive decline is often undetected
10-27-2006 · EurekAlert!
Many patients over the age of 65 who are hospitalized with an acute illness experience a subtle change in their cognitive ability that often goes undiagnosed, untreated and under-reported. As a result, a patient's ability to make decisions about his or her medical treatment may be negatively impacted.
Similar news · Read more »
Antipsychotic drugs increase risk of death in older people with dementia
06-04-2007 · EurekAlert!
The following articles will be highlighted in the upcoming edition of the Annals of Internal Medicine: "Antipsychotic Drugs Increase Risk of Death in Older People with Dementia"; "Exercise Therapy Plus Advice Improved Low Back Pain at 6 Weeks But Not at One Year"; "Changes in Health Insurance Status Results in Changes in Health Care"; and "Two Studies: Medical Residency Work-Hour Cap Doesn't Damage Patients' Health and Improves Outcomes in Some Diagnoses."
Similar news · Read more »
Preliminary results suggest Certolizumab Pegol is effective in reducing signs and symptoms
06-14-2007 · EurekAlert!
Fifty-nine percent of patients receiving certolizumab pegol 200mg plus methotrexate, and 61 percent of patients receiving certolizumab pegol 400mg plus methotrexate every two weeks achieved a 20 percent improvement in symptoms (known as an American College of Rheumatology 20 Response) after 24 weeks' treatment, according to a study presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. Only 14 percent of patients receiving methotrexate alone achieved an ACR20 response over the same period, highlighting the superiority of the treatment combination at both doses of certolizumab pegol in patients refractory to methotrexate.
Similar news · Read more »
Violence in schizophrenia patients more likely among those with childhood conduct problems
07-02-2007 · EurekAlert!
Some people with schizophrenia who become violent may do so for reasons unrelated to their current illness, according to a new study analyzing data from the Clinical Antipsychotic Trials for Intervention Effectiveness.
Similar news · Read more »
Combination therapy stops loss of kidney function in rare genetic disease
07-25-2007 · EurekAlert!
A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, Mass.) -- is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
Similar news · Read more »
Cognitive impairment link found in older adults taking popular stomach acid medications
08-03-2007 · EurekAlert!
Long-term use of histamine2 receptor antagonists, one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults. According to an Indiana University School of Medicine and Regenstrief Institute study published in the August issue of the Journal of the American Geriatrics Society, the risk for showing signs of cognitive impairment is 2.5 times greater for patients using these medications long-term.
Similar news · Read more »